摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-dimethyl-6-(3,5-bis(trifluoromethyl)-phenyl)isoxazolo[3,4-d]pyridazin-7(6H)-one | 263890-16-0

中文名称
——
中文别名
——
英文名称
3,4-dimethyl-6-(3,5-bis(trifluoromethyl)-phenyl)isoxazolo[3,4-d]pyridazin-7(6H)-one
英文别名
6-[3,5-Bis(trifluoromethyl)phenyl]-3,4-dimethyl-[1,2]oxazolo[3,4-d]pyridazin-7-one
3,4-dimethyl-6-(3,5-bis(trifluoromethyl)-phenyl)isoxazolo[3,4-d]pyridazin-7(6H)-one化学式
CAS
263890-16-0
化学式
C15H9F6N3O2
mdl
——
分子量
377.246
InChiKey
ZBSIEGTZMUSKIS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    26
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    58.7
  • 氢给体数:
    0
  • 氢受体数:
    10

反应信息

  • 作为反应物:
    描述:
    3,4-dimethyl-6-(3,5-bis(trifluoromethyl)-phenyl)isoxazolo[3,4-d]pyridazin-7(6H)-one 、 alkaline earth salt of/the/ methylsulfuric acid 以 四氢呋喃 为溶剂, 生成 6-(3,5-bistrifluoromethylphenyl)-4-methyl-3-(1,3-diphenylpropan-2-yl)-isoxazolo[3,4-d]pyridazin-7(6H)-one
    参考文献:
    名称:
    异恶唑并[3,4-d]哒嗪酮的横向金属化对代谢型谷氨酸受体选择性正调节剂的命中先导开发
    摘要:
    异恶唑并[3,4-d]哒嗪酮 ([3,4-d]s) 先前已被证明对代谢型谷氨酸受体 (mGluR) 亚型 2 和 4 具有选择性正向调节作用,而与 mGluR1a、mGluR5 没有功能性交叉反应,或 mGluR8。正如同源模型所表明的,制备了额外的类似物以进入更多的变构口袋并实现更高的结合亲和力。生成了两组不同的类似物。一种使用完全形成的[3,4-d]和带有或不带有卤素的N6-芳基。它们在异恶唑的 C3 处成功进行了选择性横向金属化和亲电猝灭 (LM&EQ)。在第二组类似物中,通过 4-苯乙酰基-3-乙氧羰基-5-甲基异恶唑与相应的肼缩合,在 [3,4-d] 环的 C4 位引入苯基,生成 3 ,4-ds 2b 和 2j 至 2n。
    DOI:
    10.3390/molecules28196800
  • 作为产物:
    描述:
    3,5-双(三氟甲基)苯肼4-乙酰基-5-甲基异恶唑-3-甲酸乙酯 以96%的产率得到3,4-dimethyl-6-(3,5-bis(trifluoromethyl)-phenyl)isoxazolo[3,4-d]pyridazin-7(6H)-one
    参考文献:
    名称:
    Isoxazole analogues bind the System xc- transporter: Structure–activity relationship and pharmacophore model
    摘要:
    Analogues of amino methylisoxazole propionic acid (AMPA), were prepared from a common intermediate 12, including lipophilic analogues using lateral metalation and electrophilic quenching, and were evaluated at System x(c)(-). Both the 5-naphthylethyl-(16) and 5-naphthylmethoxymethyl-(17) analogues adopt an E-conformation in the solid state, yet while the former has robust binding at System x(c)(-), the latter is virtually devoid of activity. The most potent analogues were amino acid naphthyl-ACPA 7g, and hydrazone carboxylic acid, 11e Y = Y' = 3,5-(CF3)(2), which both inhibited glutamate uptake by the System x(c)(-) transporter with comparable potency to the endogenous substrate cystine, whereas in contrast the closed isoxazolo[3,4-d] pyridazinones 13 have significantly lower activity. A preliminary pharmacophore model has been constructed to provide insight into the analogue structure-activity relationships. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.11.001
点击查看最新优质反应信息

文献信息

  • Isoxazole analogues bind the System xc- transporter: Structure–activity relationship and pharmacophore model
    作者:Sarjubhai A. Patel、Trideep Rajale、Erin O’Brien、David J. Burkhart、Jared K. Nelson、Brendan Twamley、Alex Blumenfeld、Monika I. Szabon-Watola、John M. Gerdes、Richard J. Bridges、Nicholas R. Natale
    DOI:10.1016/j.bmc.2009.11.001
    日期:2010.1
    Analogues of amino methylisoxazole propionic acid (AMPA), were prepared from a common intermediate 12, including lipophilic analogues using lateral metalation and electrophilic quenching, and were evaluated at System x(c)(-). Both the 5-naphthylethyl-(16) and 5-naphthylmethoxymethyl-(17) analogues adopt an E-conformation in the solid state, yet while the former has robust binding at System x(c)(-), the latter is virtually devoid of activity. The most potent analogues were amino acid naphthyl-ACPA 7g, and hydrazone carboxylic acid, 11e Y = Y' = 3,5-(CF3)(2), which both inhibited glutamate uptake by the System x(c)(-) transporter with comparable potency to the endogenous substrate cystine, whereas in contrast the closed isoxazolo[3,4-d] pyridazinones 13 have significantly lower activity. A preliminary pharmacophore model has been constructed to provide insight into the analogue structure-activity relationships. (C) 2009 Elsevier Ltd. All rights reserved.
  • The Lateral Metalation of Isoxazolo[3,4-d]pyridazinones towards Hit-to-Lead Development of Selective Positive Modulators of Metabotropic Glutamate Receptors
    作者:Christina A. Gates、Donald S. Backos、Philip Reigan、Nicholas R. Natale
    DOI:10.3390/molecules28196800
    日期:——
    Isoxazolo[3,4-d] pyridazinones ([3,4-d]s) were previously shown to have selective positive modulation at the metabotropic glutamate receptor (mGluR) Subtypes 2 and 4, with no functional cross-reactivity at mGluR1a, mGluR5, or mGluR8. Additional analogs were prepared to access more of the allosteric pocket and achieve higher binding affinity, as suggested by homology modeling. Two different sets of
    异恶唑并[3,4-d]哒嗪酮 ([3,4-d]s) 先前已被证明对代谢型谷氨酸受体 (mGluR) 亚型 2 和 4 具有选择性正向调节作用,而与 mGluR1a、mGluR5 没有功能性交叉反应,或 mGluR8。正如同源模型所表明的,制备了额外的类似物以进入更多的变构口袋并实现更高的结合亲和力。生成了两组不同的类似物。一种使用完全形成的[3,4-d]和带有或不带有卤素的N6-芳基。它们在异恶唑的 C3 处成功进行了选择性横向金属化和亲电猝灭 (LM&EQ)。在第二组类似物中,通过 4-苯乙酰基-3-乙氧羰基-5-甲基异恶唑与相应的肼缩合,在 [3,4-d] 环的 C4 位引入苯基,生成 3 ,4-ds 2b 和 2j 至 2n。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐